Cytogenetically Normal Acute Myeloid Leukaemia (CN-AML): Favourable Prognosis of NPM1 Mutation may have Linkage with High Expression of HOXA and PBX3 Genes

被引：0
|
作者：
Akhter, Ariz [1 ]
Elyamany, Ghaleb [2 ]
Roshan, Tariq [3 ]
Mansoor, Adnan [1 ]
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Prince Sultan Mil Med City, Riyadh, Saudi Arabia
[3] Univ Calgary, Alberta Precis Labs, Calgary, AB, Canada
来源：
LABORATORY INVESTIGATION | 2023年 / 103卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1065
引用
收藏
页码：S1084 / S1085
页数：2
相关论文
共 36 条
  • [21] IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
    Paschka, Peter
    Schlenk, Richard F.
    Gaidzik, Verena I.
    Habdank, Marianne
    Kroenke, Jan
    Bullinger, Lars
    Spaeth, Daniela
    Kayser, Sabine
    Zucknick, Manuela
    Goetze, Katharina
    Horst, Heinz-A.
    Germing, Ulrich
    Doehner, Hartmut
    Doehner, Konstanze
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (22) : 3636 - 3643
  • [22] CD34, CD56 and CD2 Are Predictive of NPM1 Mutation, FLT3-ITD and Their Favorable Prognosis Combination in Cytogenetically Normal Acute Myeloid Leukemia.
    Dalal, Bakul I.
    Manna, Mita
    Pi, Steven
    Di Sauro, Giovanna
    Hogge, Donna E.
    BLOOD, 2009, 114 (22) : 630 - 630
  • [23] FLT3 ITD Mutation is an Independent Poor Prognostic Indicator Regardless of NPM1 Gene Mutation Status in Cytogenetically Normal Acute Myeloid Leukemia Patients: the New Mexico Experience
    Hunt, K. E.
    Gale, J. M.
    Vasef, M. A.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 631 - 631
  • [24] The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia - Response to Rashidi etal.
    McGregor, Andrew Kenneth
    Moulton, Deborah
    Bown, Nick
    Cuthbert, Gavin
    Bourn, David
    Mathew, Susanna
    Dang, Raymond
    Mounter, Phillip
    Jones, Gail
    LEUKEMIA & LYMPHOMA, 2016, 57 (08) : 1980 - 1981
  • [25] High CD200 expression is associated with poor prognosis in cytogenetically normal acute myeloid leukemia, even in FlT3-ITD-/NPM1+patients
    Tiribelli, Mario
    Raspadori, Donatella
    Geromin, Antonella
    Cavallin, Margherita
    Sirianni, Santina
    Simeone, Erica
    Bocchia, Monica
    Fanin, Renato
    Damiani, Daniela
    LEUKEMIA RESEARCH, 2017, 58 : 31 - 38
  • [26] Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics
    Seyyedi, Samaneh Sadat
    Soleimani, Masoud
    Yaghmaie, Marjan
    Ajami, Monireh
    Ajami, Mansoureh
    Pourbeyranvand, Shahram
    Alimoghaddam, Kamran
    Akrami, Seyed Mohammad
    TUMOR BIOLOGY, 2016, 37 (04) : 4841 - 4847
  • [27] Poor Outcome of RUNX1-Mutated (RUNX1-mut) Patients (Pts) with Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) and Associated Gene- and MicroRNA (miR) Expression Signatures
    Mendler, Jason H.
    Maharry, Kati
    Radmacher, Michael D.
    Mrozek, Krzysztof
    Kohlschmidt, Jessica
    Nicolet, Deedra
    Becker, Heiko
    Metzeler, Klaus H.
    Schwind, Sebastian
    Whitman, Susan P.
    Blum, William
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Carter, Thomas H.
    Wetzler, Meir
    Moore, Joseph O.
    Carroll, Andrew J.
    Baer, Maria R.
    Larson, Richard A.
    Caligiuri, Michael A.
    Marcucci, Guido
    Bloomfield, Clara D.
    BLOOD, 2011, 118 (21) : 1476 - 1477
  • [28] RUNX1 mutation and elevated FLT3 gene expression cooperates to induce inferior prognosis in cytogenetically normal acute myeloid leukemia patients
    Rehman, Atia
    Akram, Afia Muhammad
    Chaudhary, Asma
    Sheikh, Nadeem
    Hussain, Zawar
    Alsanie, Walaa F.
    Rehman, Rahat Abdul
    Hameed, Naila
    Saleem, Tayyaba
    Zafar, Amjad
    Absar, Muhammad
    Iqbal, Zafar
    Alhazmi, Alaa
    Baeshen, Hosam Ali
    Mohammedsaleh, Zuhair M.
    Qamer, Samina
    Sayed, Samy
    Gaber, Ahmed
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (09) : 4845 - 4851
  • [29] ACUTE MYELOID LEUKEMIA (AML) PATIENTS HARBOURING BOTH, FLT3-ITD AND NPM1 MUTATION, MAY BENEFIT FROM A MINIMAL RESIDUAL DISEASES (MRD) GUIDED TRANSPLANT DECISION
    Schiller, J.
    Praulich, I.
    Hallek, M.
    Kreuzer, K.
    HAEMATOLOGICA, 2013, 98 : 22 - 23
  • [30] Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD)
    Zhou, Ya-Lan
    Wu, Li-Xin
    Gale, Robert Peter
    Wang, Zi-Long
    Li, Jin-Lan
    Jiang, Hao
    Jiang, Qian
    Jiang, Bin
    Cao, Shan-Bo
    Lou, Feng
    Sun, Ying
    Wang, Cheng-Cheng
    Liu, Yan-Rong
    Wang, Yu
    Chang, Ying-Jun
    Xu, Lan-Ping
    Zhang, Xiao-Hui
    Liu, Kai-Yan
    Ruan, Guo-Rui
    Huang, Xiao-Jun
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (02) : 274 - 283
1234